Form 4 UNITED THERAPEUTICS Corp For: Aug 15 Filed by: ROTHBLATT MARTINE A
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
August 20, 2024 4:53 AM EDTWells Fargo analyst Tiago Fauth raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $380.00 (from $350.00) while maintaining a Overweight rating.
The analyst comments "Thoughts on the stock. We previously modeled Yutrepia launching this year, as the FDA faced no legal hurdles in... More
